Galectin Therapeutics preclinical data

In a mouse model of diabetic nephropathy, GR-MD-02 reduced glomerular lesions and the area of interstitial fibrosis. Galectin plans to start Phase I testing of the galectin-3 (LGALS3) and LGALS1 inh...